Perfil
Philip J.
Barr was the founder of Arriva Pharmaceuticals, Inc. founded in 1997, where he held the title of Chief Scientific Officer from 1997 to 2011.
Dr. Barr is also the founder of BayMedica, Inc. Dr. Barr's current job is as a Principal at The University of California, San Francisco.
Dr. Barr's former job was as a Director-Molecular Biology at Chiron Corp.
Cargos activos de Philip J. Barr
| Empresas | Cargo | Inicio |
|---|---|---|
The University of California, San Francisco
The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
BayMedica, Inc.
BayMedica, Inc. BiotechnologyHealth Technology Operates biosynthetic platform for the production of cannabinoids | Fundador | - |
Antiguos cargos conocidos de Philip J. Barr.
| Empresas | Cargo | Fin |
|---|---|---|
Arriva Pharmaceuticals, Inc.
Arriva Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops anti-inflammatory therapies for treating respiratory diseases | Fundador | 19/01/2011 |
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Corporate Officer/Principal | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Health Technology |
Arriva Pharmaceuticals, Inc.
Arriva Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops anti-inflammatory therapies for treating respiratory diseases | Health Technology |
The University of California, San Francisco
The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BayMedica, Inc.
BayMedica, Inc. BiotechnologyHealth Technology Operates biosynthetic platform for the production of cannabinoids | Health Technology |
- Bolsa de valores
- Insiders
- Philip J. Barr
















